Researchers today (Nov. 8, 2024) are releasing the flagship dataset from an ambitious study of biomarkers and environmental factors that might influence the development of type 2 diabetes.
M1 Kliniken AG (von First Berlin Equity Research GmbH) – Biotech Investments
Original-Research: M1 Kliniken AG – from First Berlin Equity Research GmbH 06.09.2024 / 14:30 CET/CESTDissemination of a Research, transmitted by EQS News – a service